Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19.
Baldi F, Dentone C, Mikulska M, Fenoglio D, Mirabella M, Magnè F, Portunato F, Altosole T, Sepulcri C, Giacobbe DR, Uras C, Scavone G, Taramasso L, Orsi A, Cittadini G, Filaci G, Bassetti M.
Baldi F, et al. Among authors: filaci g.
Front Med (Lausanne). 2023 Jan 9;9:1062450. doi: 10.3389/fmed.2022.1062450. eCollection 2022.
Front Med (Lausanne). 2023.
PMID: 36698815
Free PMC article.